USS Investment Management Ltd Sells 812,659 Shares of Colgate-Palmolive Company $CL
USS Investment Management Ltd significantly reduced its holdings in Colgate-Palmolive Company, selling 812,659 shares, which represents a 37.4% decrease in its stake. Despite this, Colgate-Palmolive (NYSE:CL) reported strong third-quarter earnings, beating analyst estimates for both EPS and revenue, with revenue growing 4.6% year-over-year. The company also declared a quarterly dividend of $0.53 per share, and analysts maintain a "Moderate Buy" consensus with an average price target of $101.22.
Procter & Gamble Wants $10 Billion in Savings and Fewer Factory Workers
Procter & Gamble (PG) aims to achieve up to $10 billion in productivity savings by fiscal 2030, which includes reducing its product supply workforce by 20% to 30%. This initiative is intended to fund reinvestment for faster market growth rather than directly boosting near-term earnings, as fiscal 2027 core EPS guidance already accounts for significant increases in raw material, energy, and freight costs. The plan extends P&G's previous non-manufacturing job cuts to include plant and logistics workers, emphasizing automation and data use.
VEN ETF Holdings List — AMEX:VEN
This article provides a detailed list of the holdings for the Teucrium Venezuela Future Opportunities ETF (VEN) as of November 18, 2026. It includes information on the symbol, weight percentage, shares, and market value for each of the top holdings, such as Clorox, Grupo Bimbo, Diageo, and Yum! Brands. The ETF is listed on NYSE Arca.
Colgate-Palmolive (CL) Stock: $96.88, Down 1.99% Nov 19
Colgate-Palmolive (CL) shares fell 1.99% to $96.88 on November 19, 2026, on heavier-than-usual volume, placing it near its 20-day moving average. Despite a cooling of upward momentum indicated by MACD and RSI, the stock's uptrend remains intact as it trades above its 20-day and 50-day averages. JournalArta issued a "HOLD (wait & see)" verdict, advising investors to await a confirmed move above resistance before considering the pullback finished.
PG Jumps 17.4% in Three Months as Investors Weigh What Comes Next
Procter & Gamble (PG) shares have increased 17.4% over the past three months, outperforming the Zacks Consumer Products - Staples sub-industry. This rally is driven by improving sales trends, with PG reporting 4% organic sales growth in fiscal first-quarter 2027, although rising input costs and mixed market-share gains present concerns. The company's valuation is currently at a premium, prompting investors to consider whether further upside is justified given operating challenges and varied peer results.
Colgate Has Raised Its Dividend for 63 Years. These 3 Staples Stocks Offer Income
This article examines three consumer staples companies—Colgate-Palmolive, Kimberly-Clark, and Hormel Foods—highlighting their long histories of dividend increases and their current financial health. While Colgate-Palmolive offers the most secure payout with 63 years of increases, Kimberly-Clark's recent Kenvue acquisition adds debt that could limit future raises, and Hormel Foods, despite a high yield, shows tighter dividend coverage. The piece advises investors to match each stock to their income priorities, whether it's reliable raises or higher current yield.
Bank of Montreal revives US oil and gas investment banking By Investing.com
Bank of Montreal (BMO) is re-entering the U.S. oil and gas investment banking sector six years after its departure, aiming to capitalize on the growing demand for natural gas driven by AI infrastructure. BMO Capital Markets is hiring Ali Akbar to lead its U.S. energy practice, focusing on midstream and energy infrastructure companies, and will bring in additional bankers from Mizuho Financial Group. This strategic move aligns with the stability of the American energy sector amidst global conflicts.
PG Jumps 17.4% in Three Months as Investors Weigh What Comes Next
The Procter & Gamble Company (PG) has seen its shares rise 17.4% in the last three months, outpacing the consumer staples sub-industry. This rally is supported by improving sales trends, with 4% organic sales growth in fiscal Q1 2027 across most categories and regions. However, rising input costs, uneven market share gains, and a higher valuation raise concerns about future upside potential.
Is PG Worth Buying as Growth Improves but Its Valuation Stays Rich?
The Procter & Gamble Company (PG) is experiencing improved operating momentum with accelerated fiscal first-quarter organic sales growth and healthy cash generation. However, its valuation remains high compared to its peers and the broader market, and the company faces significant cost pressures from commodities and other expenses. While cash flow is strong, the modest fiscal 2027 earnings growth guidance and premium valuation suggest a cautious stance for investors.
PG Raises Sales Outlook as Thorne Acquisition Adds Growth Potential
Procter & Gamble (PG) has increased its fiscal 2027 all-in sales growth outlook to 2-4% from 1-3% following the completion of its Thorne acquisition, introducing a new source of reported growth. While this boosts reported sales, the company maintained its organic sales and core earnings growth outlooks, reflecting higher financing costs, a broader restructuring program, and execution risks associated with integrating the new business. The acquisition's impact on long-term earnings and returns will depend on effective integration and cost control amid existing financial pressures and restructuring efforts.
Is PG Worth Buying as Growth Improves but Its Valuation Stays Rich?
Procter & Gamble (PG) is experiencing improved operating momentum, with fiscal first-quarter organic sales growth exceeding guidance and healthy cash generation. However, its valuation remains high compared to peers and the S&P 500, and the company faces building cost pressures, including significant commodity and energy headwinds. Despite strong cash flow and shareholder returns, a cautious stance is recommended due to the premium valuation and modest near-term earnings growth outlook.
How Many Shares of Colgate-Palmolive or Procter & Gamble Pay $1,000 a Month in Dividends?
This article compares Colgate-Palmolive (CL) and Procter & Gamble (PG) as dividend income sources for a retiree seeking $1,000 monthly. It calculates the number of shares and investment cost for each, highlighting P&G's higher yield and faster dividend growth as more appealing despite its slightly less covered dividend. The author ultimately recommends P&G for its better income prospects for retirees.
How Many Shares of Colgate-Palmolive or Procter & Gamble Pay $1,000 a Month in Dividends?
This article compares Colgate-Palmolive (CL) and Procter & Gamble (PG) as dividend income sources for retirees aiming for $1,000 a month. It finds that achieving this goal requires about 5,661 shares of CL (costing $559,600) or 2,759 shares of PG (costing $469,800), with PG offering a better yield and faster dividend growth despite a higher payout ratio. The analysis concludes that while Colgate's dividend is more comfortably covered, P&G's higher yield and growth make it the more appealing option for retirees seeking consistent income.
How Many Shares of Colgate-Palmolive or Procter & Gamble Pay $1,000 a Month in Dividends?
This article analyzes how many shares of Colgate-Palmolive (CL) and Procter & Gamble (PG) are needed to generate $1,000 in monthly dividends, comparing their respective costs, yields, and dividend growth. It concludes that P&G offers a more appealing option for retirees due to a lower initial investment, higher yield, and faster dividend growth, despite Colgate-Palmolive having a more conservative payout ratio. The article advises against putting a large sum into a single stock and highlights the importance of safe dividend stocks for retirees.
Does Procter & Gamble (PG) Have A Holiday Hit In Limited Edition Grooming?
Procter & Gamble (NYSE:PG) has launched the Old Spice Holidudes Collection, a limited-edition seasonal line of men's grooming products with holiday-themed scents. This move allows P&G to test holiday demand and gather real-world data on consumer preferences and gifting behavior. The initiative supports P&G's broader strategy of focusing on product innovation, targeted offerings, and maintaining brand strength through organic sales quality.
Kimberly-Clark vs. McDonald's: A 4.7% Yield Takes On a 2.8% Payout as Consumer Staples and Fast Food Diverge
This article compares Kimberly-Clark and McDonald's as investment options for income investors, highlighting their differing dividend yields, business models, and recent financial performance. Kimberly-Clark offers a higher yield of 4.7% with stable demand for its consumer staple products, while McDonald's provides a 2.8% payout backed by its franchise model and a long history of dividend increases. The analysis also touches on Colgate-Palmolive as another defensive consumer staple, emphasizing the trade-offs between yield, growth, and risk for each company.
Why (CL) Price Action Is Critical for Tactical Trading
This article analyzes Colgate-Palmolive Company (NYSE: CL) and provides tactical trading insights based on AI models. It highlights a strong overweight bias across all horizons, identifies a mid-channel oscillation pattern, and presents three distinct trading strategies with specific entry, target, and stop levels. The analysis emphasizes an exceptional risk-reward short setup and offers real-time updates through a PRO membership platform.
The maker of Colgate toothpaste will stream an executive chat Dec. 2; a recording will follow.
Colgate-Palmolive announced that Chief Growth Officer John Hazlin and EVP of Investor Relations Claire Ross will participate in a fireside chat at the Morgan Stanley Global Consumer & Retail Conference on December 2, 2026, at 8:00 a.m. ET. A live webcast will be available on Colgate’s website, with a recorded version accessible afterward through the Investor Center page. The company emphasized its focus on oral, personal, home, and pet care, operating globally with well-known brands.
Haleon Appoints Maria Paula Capuzzo as Chief Growth Officer — LBB
Haleon plc has appointed Maria Paula Capuzzo as its new Chief Growth Officer, effective January 1, 2027. She succeeds Filippo Lanzi, who will transition to President, Europe. Capuzzo brings nearly three decades of experience from Colgate-Palmolive, with a strong background in commercial leadership, innovation, and international general management.
Broadridge appoints Lauren Boyman as Chief Marketing and Communications Officer
Broadridge Financial Solutions Inc. (NYSE:BR) has appointed Lauren Boyman as its new Chief Marketing and Communications Officer, effective November 23. Boyman will be responsible for leading Broadridge’s global marketing and communications, including brand and digital strategy, product positioning, and corporate communications. She joins Broadridge from KPMG, where she served as Partner and Chief Marketing Officer of KPMG Americas, and will focus on strengthening Broadridge's brand and supporting growth in the evolving financial markets.
Colgate-Palmolive Company (NYSE:CL) Stock Has Average Target Price of $101.22
Analysts have given Colgate-Palmolive Company (NYSE:CL) an average "Moderate Buy" rating with a one-year target price of $101.22. The company recently surpassed quarterly earnings and revenue estimates, reporting $0.97 EPS and $5.37 billion in revenue. Despite recent insider selling, institutional investors have increased their stakes in the company.
Church & Dwight Acquires 45% Stake in BALI CURLS and BALI GENTS for US$225 Million
Church & Dwight has acquired a 45% stake in European hair care company BALI Treatment, which owns BALI CURLS and BALI GENTS, for approximately US$225 million. This strategic investment aims to expand Church & Dwight's international personal care portfolio and strengthen its position in the textured hair care market. The agreement includes an option for Church & Dwight to acquire the remaining 55% stake after two years, with the transaction expected to close in Q1 2027.
Can PG's Health Care Segment Extend Its Sales Momentum Ahead?
Procter & Gamble's Health Care segment, encompassing Oral Care and Personal Health Care, is poised for continued growth driven by improving demand, portfolio expansion, and strengthened consumer engagement. The company expects a potential recovery in seasonal cold and cough demand and the recent acquisition of Thorne to contribute to stronger sales. Peers Church & Dwight and Colgate-Palmolive are also seeing growth in their health care categories through innovation and strategic investments.
Kimberly-Clark Corporation (KMB) Latest Stock News & Headlines - Yahoo Finance
This article provides a compilation of recent news and headlines concerning Kimberly-Clark Corporation (KMB), including analyst expectations, stock fair value assessments, dividend announcements, and updates on its Kenvue acquisition. It also features performance data for KMB against the S&P 500, showing its trailing total returns.
Coles 360 names Colgate-Palmolive, Vinarchy and Nestlé at retail media awards
Coles 360, the retail media arm of Coles Group, announced the winners of its inaugural Coles 360 Awards. The awards recognize outstanding retail media campaigns and partnerships across various categories, celebrating collaborations that drive customer engagement and brand impact. Key winners included Colgate-Palmolive for Supermarket Partner of the Year, Vinarchy for Liquor Partner of the Year, and Nestlé for Best Full-Funnel Campaign.
Colgate Palmolive stock hits 52-week high at 101.19 USD By Investing.com
Colgate Palmolive stock reached a 52-week high of $101.19, reflecting a 28.25% increase over the past year and demonstrating strong investor confidence despite being considered overvalued by InvestingPro analysis. The company's robust financial health is supported by a 60.64% gross profit margin and 37 consecutive years of dividend raises. Recent Q3 2026 earnings exceeded expectations, driven by strong organic growth in emerging markets and Hill's Pet Nutrition, leading several financial firms to raise their price targets.
Colgate Palmolive stock hits 52-week high at 101.19 USD
Colgate Palmolive stock has reached a new 52-week high of $101.19, reflecting a 28.25% increase over the past year and strong investor confidence. Despite an InvestingPro analysis suggesting the stock might be overvalued, the company's solid financial health is underpinned by a 60.64% gross profit margin and 37 consecutive years of dividend increases. Recent strong third-quarter 2026 earnings, exceeding Wall Street expectations, have led several financial firms to raise their price targets for Colgate-Palmolive.
Form 4 Colgate Palmolive: Noel R. Wallace (Director, Chairman, President & CEO) For: 11 September
The article reports on a Form 4 filing for Colgate Palmolive concerning Noel R. Wallace, who serves as Director, Chairman, President & CEO. The filing is noted for September 11, indicating a transaction or change in beneficial ownership by a company insider. No specific details of the transaction are provided in the snippet.
Form 4 Colgate Palmolive: Shane Grant (COO, Americas) For: 11 September
This article reports on a Form 4 filing for Colgate Palmolive (CL), detailing an insider transaction by Shane Grant, the COO of Americas, on September 11. The article simply states the filing information without providing further details about the transaction itself.
Colgate-Palmolive (CL) Rallies On Resilient Growth Narrative As Fair Value Debate Heats Up
Colgate-Palmolive (CL) shares have rallied significantly, fueled by its steady growth, rising dividend, and focus on oral care and pet nutrition. While the share price approaches analyst targets, a debate on its fair value has emerged. One narrative suggests CL is 15% overvalued based on normalized profit margins, while a discounted cash flow model indicates it could be undervalued by over 20%.
Earnings call transcript: Kolibri Global Energy misses Q3 2026 EPS as shares fall
Kolibri Global Energy Inc. reported adjusted earnings of $0.10 per share on revenue of $18.37 million for Q3 2026, missing analysts' estimates and causing shares to fall over 10%. Despite the earnings miss, the company saw a 22% revenue increase year-over-year and highlighted promising results from a new drilling zone in the False Caney formation, which is expected to significantly increase reserves and production in the future. Management expressed optimism for continued growth and strong cash flows into 2027, with plans to accelerate or decelerate drilling activity based on market conditions.
P&G claims toothpaste breakthrough on par with stannous fluoride
Procter & Gamble is introducing a new toothpaste innovation for its Crest line, utilizing β-acids extracted from hops. This ingredient is claimed to be the biggest breakthrough since stabilized stannous fluoride, effectively reducing gum bleeding by breaking up biofilms on teeth. P&G unveiled this new technology at an event in Cincinnati, highlighting its potential to improve dental health.
Procter & Gamble Has Raised Its Dividend for 70 Straight Years. Where's the Price Target Now?
Procter & Gamble (PG) has received a "BUY" rating and a $184 price target from 24/7 Wall St., indicating about 10% upside following a recent earnings beat. The company, known for 70 consecutive years of dividend increases, is performing strongly with volume-led growth and market share gains, although rising commodity costs pose a threat to margins. Despite these challenges, productivity savings and planned price increases are expected to help offset cost pressures.
What If the Fed Doubles the Rate Hike in December? These 5 Dividend Stocks Could Prosper
With the Federal Reserve's December meeting approaching, this article explores the potential impact of an aggressive half-point rate hike on dividend stocks. It highlights five companies—JPMorgan Chase, PNC Financial Services, Prudential Financial, Exxon Mobil, and Colgate-Palmolive—that could benefit, though each also faces specific risks. While a quarter-point hike remains the most likely scenario, market participants are closely watching October inflation data for further indications.
Zacks Industry Outlook Highlights Colgate-Palmolive, Kimberly-Clark, BJ's Wholesale and Ollie's Bargain Outlet
The Zacks Consumer Products-Staples industry faces significant headwinds due to rising costs, consumer price sensitivity, and currency fluctuations, leading to a "Dull Prospects" industry rank. Despite these challenges, companies like Colgate-Palmolive, Kimberly-Clark, BJ's Wholesale Club, and Ollie's Bargain Outlet are employing strategies such as cost optimization, product innovation, and expanding digital capabilities to maintain competitive positions. The article highlights specific strengths and recent performance of these four companies, noting their efforts to adapt to evolving consumer behavior and economic pressures.
VML Elevates Debbi Vandeven in Push For ‘Human-First’ Creative
VML has elevated Debbi Vandeven to global president, a new role in which she will oversee over 55 markets while retaining her position as global chief creative officer. This is the first major executive appointment by incoming global CEO Eric Campbell. Vandeven, a 27-year veteran of VML, aims to bridge the organizational gaps between creative, technology, and business to foster a "human-first" creative approach.
These 5 Dividend Aristocrats® Have Raised Payouts for Decades
This article highlights five Dividend Aristocrats® that have consistently raised their payouts for decades: Coca-Cola, Procter & Gamble, Johnson & Johnson, PepsiCo, and Colgate-Palmolive. These companies are also Dividend Kings, having increased dividends for at least 50 years, thanks to their recession-resistant business models in consumer staples and healthcare. The piece suggests that focusing on these reliable dividend stocks can provide stability and help investors navigate volatile markets by offering a steady income stream.
These 5 Dividend Aristocrats® Have Raised Payouts for Decades
The article highlights five Dividend Aristocrats—Coca-Cola, Procter & Gamble, Johnson & Johnson, PepsiCo, and Colgate-Palmolive—known for consistently increasing their dividends for decades, qualifying them as "Dividend Kings." These companies operate in recession-resistant sectors like consumer staples and healthcare, offering stability and reliable income streams for investors, especially during volatile market conditions. The author suggests focusing on dividends rather than stock prices to maintain investment through difficult times and avoid emotional decisions.
Six Flags appoints Adam Boal as procurement chief
Six Flags Entertainment Corporation has appointed Adam Boal as its new chief procurement officer. Boal brings extensive experience from CBRE and AstraZeneca, where he managed billions in corporate and client spending, and will be responsible for strengthening Six Flags' procurement capabilities and supplier partnerships. His appointment aligns with the company's ongoing efforts to enhance its business and operations.
Colgate-Palmolive fined $930,000 by US authorities over ‘violations’ of chemical reporting
Colgate-Palmolive has agreed to a $930,000 settlement with the US Environmental Protection Agency (EPA) for failing to report numerous chemical substances imported between 2016 and 2019, violating the Toxic Substances Control Act (TSCA) Chemical Data Reporting (CDR) Rule. The company has since certified compliance and paid the penalty. The EPA emphasizes that data reporting is crucial for protecting human health and the environment, and worked with Colgate-Palmolive to ensure compliance.
Colgate-Palmolive Pays US$930,000 EPA Penalty Over Chemical Imports
Colgate-Palmolive has agreed to pay a US$930,000 penalty to the US Environmental Protection Agency (EPA) for failing to report significant quantities of imported chemicals. An inspection in March 2023 found the company had not submitted required information on chemical imports between 2016 and 2019, identifying 47 chemicals exceeding reporting thresholds. This settlement emphasizes the critical need for robust chemical import reporting and regulatory compliance for global cosmetics and personal care manufacturers in the US.
Colgate-Palmolive signals more price hikes as U.S. sales fall
Colgate-Palmolive is considering further price increases due to rising manufacturing and transportation costs, despite experiencing weaker demand and declining sales in the U.S. during the third quarter of 2026. The company is also focusing on a strategy to introduce more expensive, premium products and enhance its marketing efforts to attract customers and improve profitability. While overall global revenue increased, North American sales fell, prompting a shift towards higher-value offerings and a cautious outlook on inflationary pressures for 2027.
Kimberly-Clark vs. Colgate-Palmolive: Which Dividend Stock Pays You More in 10 Years?
This article compares Kimberly-Clark (KMB) and Colgate-Palmolive (CL) as dividend stocks, focusing on which would pay more over a decade. KMB currently offers a higher yield (4.6% vs. 2.2%) but has a tighter dividend payout ratio, especially after its recent Kenvue acquisition. CL, while having a lower yield, boasts a more robust cash flow coverage for its dividend. Despite KMB's integration risks, the analysis concludes that its higher initial yield would likely result in greater total dividend payments over 10 years, assuming both companies maintain their historical dividend growth rates.
Can Colgate-Palmolive (CL) Justify Its 42% Run On Cash Flow?
Colgate-Palmolive (CL) has seen a 41.8% stock return over the past 5 years, prompting questions about whether its cash flow supports this gain. A Discounted Cash Flow (DCF) model estimates the company's intrinsic value to be meaningfully above its current $98.09 share price, based on steady growth in free cash flow and recent strong earnings. However, different narratives exist, with some analysts viewing the stock as fairly valued due to premium products and emerging markets, while others see it as 13% overvalued, citing concerns about profit normalization and valuation multiples.
Priyam Kanchwala Elevated to Strategy and Brand Experience Media Lead at Colgate-Palmolive (India) Ltd.
Priyam Kanchwala has been promoted to Strategy and Brand Experience Media Lead at Colgate-Palmolive (India) Ltd., moving up from Senior Manager – Integrated Media. In this new capacity, Kanchwala will oversee strategic media initiatives and enhance brand experiences through innovative and consumer-focused media strategies. Kanchwala brings extensive experience in media planning, brand building, and digital strategy from previous roles at Marico Limited, Madison World, and Mediaedge:cia.
Priyam Kanchwala named strategy and brand experience media lead at Colgate-Palmolive India
Priyam Kanchwala has been appointed as the strategy and brand experience media lead at Colgate-Palmolive (India) Ltd, effective November 2026. He brings extensive experience from both agency and FMCG marketing roles, having previously served as senior manager of integrated media at Colgate-Palmolive and media manager at Marico Limited. His career also includes significant time at Madison World, where he specialized in media strategy for FMCG brands.
EPA Announces Settlement for Failure to Report Large Quantities of Chemical Imports
The U.S. Environmental Protection Agency (EPA) announced a settlement with Colgate-Palmolive Corporation for violations of the Toxic Substances Control Act (TSCA) Chemical Data Reporting (CDR) rule. Colgate-Palmolive failed to report numerous chemical substances imported between 2016 and 2019, revealing 47 chemicals imported above the reporting threshold. The company has certified compliance and paid a $930,000 penalty.
Colgate-Palmolive Company $CL Shares Sold by Alps Advisors Inc.
Alps Advisors Inc. significantly reduced its stake in Colgate-Palmolive (CL) by 28.9% in the third quarter, selling 14,396 shares. This comes as Colgate-Palmolive reported strong quarterly earnings, beating analyst estimates with EPS of $0.97 and revenue of $5.37 billion, and declared a quarterly dividend of $0.53 per share. The company currently holds a "Moderate Buy" consensus rating among analysts with a price target of $101.22.
Insider Move: LORRIE NORRINGTON Exercises Options, Realizing $108K At Colgate-Palmolive
Lorrie Norrington, a Director at Colgate-Palmolive (NYSE: CL), recently exercised company stock options for 4,170 shares, realizing a value of $108,711. The options were exercised at $71.56 per share, while Colgate-Palmolive shares were trading at $97.63, reflecting a 0.32% decline on the day of the report. The article also provides a detailed financial overview of Colgate-Palmolive, including revenue growth, profitability metrics, debt management, and valuation metrics, alongside an explanation of the significance of insider transactions for investors.
Colgate-Palmolive (India) to participate in investor meetings in Nov 2026
Colgate-Palmolive (India) Limited is set to participate in two institutional investor meetings in mid-November 2026, hosted by JM Financial and CLSA. The company will engage with analysts through physical group discussions on November 16 and 18, 2026, but will not share any presentation materials or unpublished price sensitive information (UPSI). These meetings are in compliance with SEBI regulations and the schedule is subject to change.